logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
26/08/2025
Abbott received regulatory approval in Thailand for the first teriparatide biosimilar, expanding access to bone disease treatment medications.
Latest
1 m ago
Philip: Net profit increased by 28.72% year-on-year in the first half of 2025.
2 m ago
Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) obtained the "Drug Registration Certificate" for Saku Polbuxartan Nabbesartan Tablets.
2 m ago
(HEDUAN Intelligence): Net profit for the first half of 2025 was 9.5131 million yuan, a year-on-year decrease of 11.39%.
2 m ago
Suntec Joint Stock Company: The company is not involved in "data center" related business.
2 m ago
New Horizon: Net profit in the first half of 2025 was 60.1657 million yuan, a year-on-year decrease of 23.70%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.